Filing Flows

Filing Flows › Fulgent Genetics (FLGT) › Who owns the stock

Who owns Fulgent Genetics (FLGT) stock

132 funds reported Fulgent Genetics (FLGT) shares in their latest 13F filings, worth $333M in all. The largest holder is BlackRock ($46.9M). Last quarter 50 funds added to their stakes and 81 cut them.

Largest holders of FLGT (13F)Largest holders of FLGT (13F)BlackRock$46.9MVanguard Group$33.1MAcadian Asset Management LLC$20.9MVanguard Capital Management LLC$16.2MJacobs Levy Equity Management$16.0MDiametric Capital, LP$14.3MAmeriprise Financial$13.8MDimensional Fund Advisors LP$12.8MGeode Capital Management, LLC$10.7MState Street$10.2M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock2,286,669$46.9Mdecrease2026-06-30
Vanguard Group1,260,014$33.1Mincrease2025-12-31
Acadian Asset Management LLC1,017,913$20.9Mdecrease2026-06-30
Vanguard Capital Management LLC789,498$16.2Mdecrease2026-06-30
Jacobs Levy Equity Management782,116$16.0Mincrease2026-06-30
Diametric Capital, LP697,784$14.3Mincrease2026-06-30
Ameriprise Financial670,084$13.8Mincrease2026-06-30
Dimensional Fund Advisors LP625,355$12.8Mdecrease2026-06-30
Geode Capital Management, LLC521,014$10.7Mdecrease2026-06-30
State Street498,673$10.2Mdecrease2026-06-30
Invenomic Capital Management LP498,287$10.2Mdecrease2026-06-30
Two Sigma Investments, LP400,986$8.2Mincrease2026-06-30
Charles Schwab Investment Management350,987$7.2Mdecrease2026-06-30
Millennium Management LLC320,910$6.6Mdecrease2026-06-30
Goldman Sachs Group307,940$6.3Mdecrease2026-06-30

Fulgent Genetics' latest quarter

Fulgent Genetics, Q3 2026: revenue $90.4M (+8% year over year), operating margin -24.9%, net loss $13.3M, operating cash flow $109M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most FLGT stock?

By the latest 13F filings: BlackRock ($46.9M); Vanguard Group ($33.1M); Acadian Asset Management LLC ($20.9M); Vanguard Capital Management LLC ($16.2M); Jacobs Levy Equity Management ($16.0M).

What is the short interest in FLGT?

2,132,685 shares were sold short at the 2026-10-15 settlement, -4.71% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.